Endocytosis and intracellular localisation of type 1 ribosome-inactivating protein saporin-s6

J Biol Regul Homeost Agents. 2012 Jan-Mar;26(1):97-109.

Abstract

Saporin-S6 is a single-chain ribosome-inactivating protein (RIP) that has low toxicity in cells and animals. When the protein is bound to a carrier that facilitates cellular uptake, the protein becomes highly and selectively toxic to the cellular target of the carrier. Thus, saporin-S6 is one of the most widely used RIPs in the preparation of immunoconjugates for anti-cancer therapy. The endocytosis of saporin-S6 by the neoplastic HeLa cells and the subsequent intracellular trafficking were investigated by confocal microscopy that utilises indirect immunofluorescence analysis and transmission electron microscopy that utilises a direct assay with gold-conjugated saporin-S6 and an indirect immunoelectron microscopy assay. Our results indicate that saporin-S6 was taken up by cells mainly through receptor-independent endocytosis. Confocal microscopy analysis showed around 30% co-localisation of saporin-S6 with the endosomal compartment and less than 10% co-localisation with the Golgi apparatus. The pathway identified by the immunofluorescence assay and transmission electron microscopy displayed a progressive accumulation of saporin-S6 in perinuclear vesicular structures. The main findings of this work are the following: i) the nuclear localisation of saporin-S6 and ii) the presence of DNA gaps resulting from abasic sites in HeLa nuclei after intoxication with saporin-S6.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA Damage
  • Endocytosis*
  • Endosomes / metabolism
  • Fluorescent Antibody Technique, Indirect
  • Golgi Apparatus / metabolism
  • HeLa Cells / metabolism
  • Humans
  • Microscopy, Confocal
  • Microscopy, Electron, Transmission
  • Protein Synthesis Inhibitors / pharmacokinetics
  • Ribosome Inactivating Proteins, Type 1 / metabolism*
  • Ribosome Inactivating Proteins, Type 1 / pharmacokinetics
  • Saporins

Substances

  • Protein Synthesis Inhibitors
  • Ribosome Inactivating Proteins, Type 1
  • Saporins